mirtazapine has been researched along with Cholangitis in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Cholangitis: Inflammation of the biliary ductal system (BILE DUCTS); intrahepatic, extrahepatic, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Depression is prevalent in primary biliary cholangitis (PBC) patients." | 1.48 | The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes. ( Almishri, W; Frolkis, AD; Kaplan, GG; Patten, S; Shaheen, AA; Swain, MG; Vallerand, I, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shaheen, AA | 1 |
| Kaplan, GG | 1 |
| Almishri, W | 1 |
| Vallerand, I | 1 |
| Frolkis, AD | 1 |
| Patten, S | 1 |
| Swain, MG | 1 |
1 other study available for mirtazapine and Cholangitis
| Article | Year |
|---|---|
The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes.
Topics: Aged; Antidepressive Agents; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Cohort Studies; D | 2018 |